Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans

被引:172
|
作者
Sullivan, DJ [1 ]
Moran, GP [1 ]
Pinjon, E [1 ]
Al-Mosaid, A [1 ]
Stokes, C [1 ]
Vaughan, C [1 ]
Coleman, DC [1 ]
机构
[1] Univ Dublin Trinity Coll, Dublin Dent Sch & Hosp, Dept Oral Med Oral Surg & Oral Pathol, Microbiol Res Unit, Dublin 2, Ireland
关键词
Candida dubliniensis; Candida albicans; epidemiology; virulence; resistance;
D O I
10.1016/S1567-1356(03)00240-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Candida dubliniensis is a pathogenic yeast species that was first identified as a distinct taxon in 1995. Epidemiological studies have shown that C dubliniensis is prevalent throughout the world and that it is primarily associated with oral carriage and oropharyngeal infections in human immunodeficiency virus (HIV)-infected and acquired immune deficiency syndrome (AIDS) patients. However, unlike Candida albicans, C dubliniensis is rarely found in the oral microflora of normal healthy individuals and is responsible for as few as 2% of cases of candidemia (compared to approximately 65% for C albicans). The vast majority of C dubliniensis isolates identified to date are susceptible to all of the commonly used antifungal agents, however, reduced susceptibility to azole drugs has been observed in clinical isolates and can be readily induced in vitro. The primary mechanism of fluconazole resistance in C dubliniensis has been shown to be overexpression of the major facilitator efflux pump Mdr1p. It has also been observed that a large number of C dubliniensis strains express a non-functional truncated form of Cdr1p, and it has been demonstrated that this protein does not play a significant role in fluconazole resistance in the majority of strains examined to date. Data from a limited number of infection models reflect findings from epidemiological studies and suggest that C dubliniensis is less pathogenic than C albicans. The reasons for the reduced virulence of C dubliniensis are not clear as it has been shown that the two species express a similar range of virulence factors. However, although C dubliniensis produces hyphae, it appears that the conditions and dynamics of induction may differ from those in C albicans. In addition, C. dubliniensis is less tolerant of environmental stresses such as elevated temperature and NaCl and H2O2 concentration, suggesting that C. albicans may have a competitive advantage when colonising and causing infection in the human body. It is our hypothesis that a genomic comparison between these two closely-related species will help to identify virulence factors responsible for the far greater virulence of C albicans and possibly identify factors that are specifically implicated in either superficial or systemic candidal infections. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 50 条
  • [31] The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis
    Asmundsdottir, L. R.
    Erlendsdottir, H.
    Agnarsson, B. A.
    Gottfredsson, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (06) : 576 - 585
  • [32] Multiple drug resistance in Candida albicans
    Prasad, R
    Murthy, SK
    Gupta, V
    Prasad, R
    ACTA BIOCHIMICA POLONICA, 1995, 42 (04) : 497 - 504
  • [33] Antifungal drug resistance in Candida albicans
    White, TC
    ASM NEWS, 1997, 63 (08): : 427 - 433
  • [34] Evolution of drug resistance in Candida albicans
    Cowen, LE
    Anderson, JB
    Kohn, LM
    ANNUAL REVIEW OF MICROBIOLOGY, 2002, 56 : 139 - 165
  • [35] Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections
    Moragues, MD
    Omaetxebarria, MJ
    Elguezabal, N
    Bikandi, J
    Quindós, G
    Coleman, DC
    Pontón, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) : 2999 - 3001
  • [36] Evaluation of a rapid immunochromatographic assay for identification of Candida albicans and Candida dubliniensis
    Marot-Leblond, A
    Grimaud, L
    David, S
    Sullivan, DJ
    Coleman, DC
    Ponton, J
    Robert, R
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (11) : 4956 - 4960
  • [37] Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis
    Ells, Ruan
    Kock, Johan L. F.
    Van Wyk, Pieter W. J.
    Botes, Piet J.
    Pohl, Carolina H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 124 - 128
  • [38] Pathogenesis and Virulence of Candida albicans and Candida glabrata
    Henriques, Mariana
    Williams, David
    PATHOGENS, 2020, 9 (09): : 1 - 3
  • [39] Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves
    Gil-Alonso, Sandra
    Jauregizar, Nerea
    Canton, Emilia
    Eraso, Elena
    Quindos, Guillermo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 82 (01) : 57 - 61
  • [40] Tobacco agar:: a new medium for chlamydosporulation in Candida albicans and Candida dubliniensis
    Kumar, CPG
    Menon, T
    MEDICAL MYCOLOGY, 2005, 43 (05) : 473 - 475